| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/22/2012 | US20120070835 Method of Cloning Stable Stress Tolerant Superoxide Dismutase Using Universal Primers |
| 03/22/2012 | US20120070834 Screening Methods for Transfusion Related Acute Lung Injury |
| 03/22/2012 | US20120070833 Lateral flow microfluidic assaying device and related method |
| 03/22/2012 | US20120070832 Se33 mutations impacting genotype concordance |
| 03/22/2012 | US20120070831 Amplification of Distant Nucleic Acid Targets Using Engineered Primers |
| 03/22/2012 | US20120070830 Stabilization of ozone-labile fluorescent dyes by thiourea |
| 03/22/2012 | US20120070829 Size selection of dna for chromatin analysis |
| 03/22/2012 | US20120070828 Methods for the detection and identification of extended spectrum beta lactamases |
| 03/22/2012 | US20120070827 Detection of fetal cells from maternal blood |
| 03/22/2012 | US20120070826 Lafora's disease gene |
| 03/22/2012 | US20120070825 Novel Compounds and Derivatizations of DNAs and RNAs on the Nucleobases of Pyrimidines for Function, Structure and Therapeutics |
| 03/22/2012 | US20120070824 Thermostable proteinases from thermophilic bacteria |
| 03/22/2012 | US20120070823 Method and device for automatically processing a sample |
| 03/22/2012 | US20120070822 Method for signal amplification during lateral-flow analysis |
| 03/22/2012 | US20120070821 Interference Control Panel for Evaluation of Analytical Assays For Samples Derived from Blood |
| 03/22/2012 | US20120070820 Probes and Methods for Hepatitis C Virus Typing Using Multidimensional Probe Analysis |
| 03/22/2012 | US20120070819 Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors |
| 03/22/2012 | US20120070511 Mitochondrial inhibitors and uses thereof |
| 03/22/2012 | US20120070504 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
| 03/22/2012 | US20120070459 Method for keeping a foot-and-mouth disease vaccine available for emergency vaccination |
| 03/22/2012 | US20120070450 Leukemia stem cell markers |
| 03/22/2012 | US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment |
| 03/22/2012 | US20120070443 Pde1 as a target therapeutic in heart disease |
| 03/22/2012 | US20120070442 Methods and compositions for treating cancer |
| 03/22/2012 | US20120070437 Method of identifying compounds that bind baff-r |
| 03/22/2012 | US20120070432 Treatment of pancreatic cancer using a dr5 agonist in combination with gemcitabine |
| 03/22/2012 | US20120070430 Identification of tumor-associated markers for diagnosis and therapy |
| 03/22/2012 | US20120070419 Method of altering the differentiative state of a cell and compositions thereof |
| 03/22/2012 | US20120070383 Polymeric nano-carriers with a linear dual response mechanism and uses thereof |
| 03/22/2012 | US20120070382 Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof |
| 03/22/2012 | US20120070374 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides |
| 03/22/2012 | US20120067734 Phenol crosslink for sensor membrane |
| 03/22/2012 | DE102010047283B4 Untersuchungsverfahren/Screeningverfahren unter Einbeziehung von lebenden Geweben des Blutgefäß-Systems Investigation procedure / screening processes involving living tissues of the vascular system |
| 03/22/2012 | DE102010046784A1 Verfahren und Vorrichtung zur Bestimmung von aktuellen Zuständen von Zellen in Zellbereichen Method and apparatus for determining actual states of cells in cell areas |
| 03/22/2012 | DE102010046199A1 Three-piece centrifuge, useful for the local fixation of ribonucleic acid- and deoxyribonucleic acid sequencing, comprises a bottom-mounted overflow dish and a rotational shell with a rotating lid |
| 03/22/2012 | DE102010046047A1 Substanz zur gerichtsverwertbaren Markierung Substance to be used in court marking |
| 03/22/2012 | DE102010037622A1 Verfahren zum Nachweis, Differenzieren und Quantifizieren von T-Zellpopulationen mittels der Reverse Transkription quantitativen Real-Time PCR (RT-qPCR) Technologie Methods for detection, differentiation and quantification of T cell populations by means of reverse transcription quantitative real-time PCR (RT-qPCR) technology |
| 03/22/2012 | DE102009043537B4 Verfahren und Anordnung zur Bestimmung von Zell-Vitalitäten Method and apparatus for determining cell viabilities |
| 03/22/2012 | DE102009041885B4 Separation von Mesenchymalen Stammzellen Mesenchymal stem cells separation of |
| 03/22/2012 | CA2812194A1 Functional genomics assay for characterizing pluripotent stem cell utility and safety |
| 03/22/2012 | CA2812115A1 Epigenetic markers of colorectal cancers and diagnostic methods using the same |
| 03/22/2012 | CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 03/22/2012 | CA2811493A1 Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
| 03/22/2012 | CA2811333A1 Capture probes immobilizable via l-nucleotide tail |
| 03/22/2012 | CA2811295A1 Broad spectrum antibiotic arylomycin analogs |
| 03/22/2012 | CA2811294A1 Stabilization of ozone-labile fluorescent dyes by thiourea |
| 03/22/2012 | CA2811227A1 Capture based nucleic acid detection |
| 03/22/2012 | CA2811064A1 Mutations in sptlc2 gene associated with sensory neuropathy |
| 03/22/2012 | CA2811015A1 Molecular diagnostic test for cancer |
| 03/22/2012 | CA2809877A1 Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices |
| 03/21/2012 | EP2431483A1 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 03/21/2012 | EP2431482A2 Anti-cancer drug screening method using ror |
| 03/21/2012 | EP2431481A1 Parallel polymer sequencing methods |
| 03/21/2012 | EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms |
| 03/21/2012 | EP2431479A2 Medium for the specific detection of resistant organisms |
| 03/21/2012 | EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells |
| 03/21/2012 | EP2431464A1 Aptamer that recognizes peptide |
| 03/21/2012 | EP2431463A1 Test agent for visceral obesity and use thereof |
| 03/21/2012 | EP2431377A1 Modified L-nucleic acids |
| 03/21/2012 | EP2431029A2 Method of inhibiting prostate cancer cell proliferation |
| 03/21/2012 | EP2430923A1 Compositions and methods for liver growth and liver protection |
| 03/21/2012 | EP2430461A2 Combined detection instrument for culture specimen containers and instrument for identification and/or characterization of a microbial agent in a sample |
| 03/21/2012 | EP2430446A2 Methods and compositions for analyte detection |
| 03/21/2012 | EP2430444A1 Method for identifying inhibitors against dengue virus |
| 03/21/2012 | EP2430428A1 Single-molecule detection system and methods |
| 03/21/2012 | EP2430195A2 Compositions and methods for biological sample storage |
| 03/21/2012 | EP2430193A1 Markers for detection of gastric cancer |
| 03/21/2012 | EP2430192A1 Method for detecting prokaryotic dna from a feces sample |
| 03/21/2012 | EP2430191A1 Phosphodiesterase 4d7 as prostate cancer marker |
| 03/21/2012 | EP2430190A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
| 03/21/2012 | EP2430189A1 Phosphodiesterase 9a as prostate cancer marker |
| 03/21/2012 | EP2430188A1 A method and kit for detecting antibiotic resistant bacteria |
| 03/21/2012 | EP2430187A2 Method for detecting nucleic acids |
| 03/21/2012 | EP2430186A1 Method for identifying interventions that control the translational activity of ribosomal proteins in differential mrna expression |
| 03/21/2012 | EP2430185A1 E. coli o157:h7 specific assay |
| 03/21/2012 | EP2430184A2 Sca risk stratification by predicting patient response to anti-arrhythmics |
| 03/21/2012 | EP2430183A1 Antipsychotic treatment based on drd2 or ankk1 snp genotype |
| 03/21/2012 | EP2430182A1 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
| 03/21/2012 | EP2430181A1 Hiv-1-c resistance monitoring |
| 03/21/2012 | EP2430180A1 Gene synthesis method |
| 03/21/2012 | EP2430179A1 Detection method |
| 03/21/2012 | EP2430178A1 Methods and kits for measuring toxicity and oxidative stress in live cells |
| 03/21/2012 | EP2430162A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use |
| 03/21/2012 | EP2430157A1 Antigen peptide and use thereof |
| 03/21/2012 | EP2430045A2 Carbohydrate binding module and use thereof |
| 03/21/2012 | EP2429957A1 Tagged scale inhibitors |
| 03/21/2012 | EP2429704A2 Sample processing cassette, system, and method |
| 03/21/2012 | EP2429575A1 Compositions and methods for immunodominant antigens of mycobacterium tuberculosis |
| 03/21/2012 | EP2429574A1 Compositions and methods for treating hematologic cancers targeting the sirp - cd47 interaction |
| 03/21/2012 | EP2096432B1 Method for measuring 1,5-anhydroglucitol in whole blood |
| 03/21/2012 | EP2094864B1 Use of genetic modifications in human gene chk1 which codes for checkpoint kinase 1 |
| 03/21/2012 | EP2093194B1 Fluorescent labeling agent and fluorescent labeling method |
| 03/21/2012 | EP1929045B1 Methods, compositions and kits for isothermal amplification of nucleic acids |
| 03/21/2012 | EP1815014B1 Molecular indicators of breast cancer prognosis and prediction of treatment response |
| 03/21/2012 | EP1689887B1 Methods for quantitative determination of methylation density in a dna locus |
| 03/21/2012 | EP1673626B8 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions |
| 03/21/2012 | EP1613771B1 Improved system for multi color real time pcr |
| 03/21/2012 | EP1506409B1 Assays for modulators of asparaginyl hydroxylase |
| 03/21/2012 | EP1436624B1 A method of diagnosis and treatment and agents useful for same |
| 03/21/2012 | EP1088077B2 Newcastle disease virus infectious clones, vaccines and diagnostic assays |